127 related articles for article (PubMed ID: 24854406)
1. Cancer: turning glioblastoma cells vacuous.
Cully M
Nat Rev Drug Discov; 2014 Jun; 13(6):417. PubMed ID: 24854406
[No Abstract] [Full Text] [Related]
2. Driving glioblastoma to drink.
Gilbertson RJ
Cell; 2014 Apr; 157(2):289-290. PubMed ID: 24725398
[TBL] [Abstract][Full Text] [Related]
3. The soft underbelly of tumor cells.
Shi Y; Lim SK; Parada LF
Cell Res; 2014 Aug; 24(8):910-1. PubMed ID: 24874955
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.
Kitambi SS; Toledo EM; Usoskin D; Wee S; Harisankar A; Svensson R; Sigmundsson K; Kalderén C; Niklasson M; Kundu S; Aranda S; Westermark B; Uhrbom L; Andäng M; Damberg P; Nelander S; Arenas E; Artursson P; Walfridsson J; Forsberg Nilsson K; Hammarström LGJ; Ernfors P
Cell; 2014 Apr; 157(2):313-328. PubMed ID: 24656405
[TBL] [Abstract][Full Text] [Related]
5. The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features.
Hammarström LG; Harmel RK; Granath M; Ringom R; Gravenfors Y; Färnegårdh K; Svensson PH; Wennman D; Lundin G; Roddis Y; Kitambi SS; Bernlind A; Lehmann F; Ernfors P
J Med Chem; 2016 Sep; 59(18):8577-92. PubMed ID: 27607569
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening.
Wang L; Zhao H; Cui K; Yao L; Ren M; Hao A; Smollen P; Nie F; Jin G; Liu Q; Wong ST
Biosci Trends; 2012 Aug; 6(4):192-200. PubMed ID: 23006966
[TBL] [Abstract][Full Text] [Related]
7. The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.
Baskin R; Park SO; Keserű GM; Bisht KS; Wamsley HL; Sayeski PP
PLoS One; 2014; 9(8):e105568. PubMed ID: 25162558
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.
Arden JD; Lavik KI; Rubinic KA; Chiaia N; Khuder SA; Howard MJ; Nestor-Kalinoski AL; Alberts AS; Eisenmann KM
Mol Biol Cell; 2015 Nov; 26(21):3704-18. PubMed ID: 26354425
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
Jung N; Kwon HJ; Jung HJ
Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404
[TBL] [Abstract][Full Text] [Related]
10. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
11. Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions.
Sengupta R; Barone A; Marasa J; Taylor S; Jackson E; Warrington NM; Rao S; Kim AH; Leonard JR; Piwnica-Worms D; Rubin JB
Oncotarget; 2015 Jul; 6(21):18282-92. PubMed ID: 26286961
[TBL] [Abstract][Full Text] [Related]
12. Identifying new small molecule anti-invasive compounds for glioma treatment.
Munson J; Bonner M; Fried L; Hofmekler J; Arbiser J; Bellamkonda R
Cell Cycle; 2013 Jul; 12(14):2200-9. PubMed ID: 24067366
[TBL] [Abstract][Full Text] [Related]
13. WINDOW consortium: A path towards increased therapy efficacy against glioblastoma.
Abdul KU; Houweling M; Svensson F; Narayan RS; Cornelissen FMG; Küçükosmanoglu A; Metzakopian E; Watts C; Bailey D; Wurdinger T; Westerman BA
Drug Resist Updat; 2018 Sep; 40():17-24. PubMed ID: 30439622
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 as a druggable target for glioblastoma therapy.
Banasavadi-Siddegowda YK; Welker AM; An M; Yang X; Zhou W; Shi G; Imitola J; Li C; Hsu S; Wang J; Phelps M; Zhang J; Beattie CE; Baiocchi R; Kaur B
Neuro Oncol; 2018 May; 20(6):753-763. PubMed ID: 29106602
[TBL] [Abstract][Full Text] [Related]
15. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
[TBL] [Abstract][Full Text] [Related]
16. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP.
Sander P; Mostafa H; Soboh A; Schneider JM; Pala A; Baron AK; Moepps B; Wirtz CR; Georgieff M; Schneider M
Oncotarget; 2017 May; 8(21):35124-35137. PubMed ID: 28410232
[TBL] [Abstract][Full Text] [Related]
17. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
Hothi P; Martins TJ; Chen L; Deleyrolle L; Yoon JG; Reynolds B; Foltz G
Oncotarget; 2012 Oct; 3(10):1124-36. PubMed ID: 23165409
[TBL] [Abstract][Full Text] [Related]
18. [Late and prolonged pseudoprogression in serial posttreatment MRI due to use of new chemotherapy concepts to treat malignant glioblastoma].
Ganslandt O
Strahlenther Onkol; 2013 Aug; 189(8):706-7. PubMed ID: 23824105
[No Abstract] [Full Text] [Related]
19. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
[TBL] [Abstract][Full Text] [Related]
20. ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration.
Fròsina G; Profumo A; Marubbi D; Marcello D; Ravetti JL; Daga A
Radiat Oncol; 2018 Apr; 13(1):76. PubMed ID: 29685176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
